Devendra Billimoria V - 09 Aug 2023 Form 4 Insider Report for LIMEADE, INC

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Aug 2023, 16:37:34 UTC
Prior SEC filing
03 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul Crick, Attorney-in-Fact

Key filing fact

Devendra Billimoria V filed Form 4 for LIMEADE, INC on 09 Aug 2023.

Key facts

  • This page summarizes Devendra Billimoria V's Form 4 filing for LIMEADE, INC.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Aug 2023, 16:37.

Change

  • Previous filing in this sequence was filed on 03 Oct 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-475,831
Change %
-100%
Price
Shares after
0
Date
09 Aug 2023
Ownership
By Family Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Devendra Billimoria V is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

On August 9, 2023 (the "Closing Date"), WebMD Health Corp, a Delaware corporation ("Buyer"), acquired the Company pursuant to a certain Agreement and Plan of Merger entered into by and among the Company, Buyer and Lotus Merger Sub, Inc. a Washington corporation and wholly owned subsidiary of Buyer ("Merger Sub"), dated as of June 8, 2023 (the "Merger Agreement"). In accordance with the Merger Agreement, the Company merged with and into Merger Sub, with the Company surviving such merger as a wholly owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Company's common stock (other than certain excluded shares) automatically converted into the right to receive USD$0.284 in cash.

SEC remarks

By virtue of the Merger Agreement, the reporting person has ceased being a Section 16 officer of the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .